Home › Entities › clinical_trial › Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19

Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19

clinical trial
MedicalStudy clinical_trial Q97047732
Press Enter · cited answer in seconds

Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19

Summary

Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 is a clinical trial[1].

Key Facts

  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 is in the country of South Korea[2].
  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19's instance of is recorded as clinical trial[3].
  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19's start time is recorded as +2020-06-22T00:00:00Z[4].
  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19's end time is recorded as +2022-02-22T00:00:00Z[5].
  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19's main subject is recorded as INO-4800[6].
  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19's main subject is recorded as severe acute respiratory syndrome[7].
  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19's number of participants is recorded as {'unit': '1', 'amount': '+160'}[8].
  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19's title is recorded as A Phase I/IIa, Dose-Ranging Trial to Evaluate Safety, Tolerability and Immunogenicity of INO-4800, a Prophylactic Vaccine Against SARS-CoV-2, Administered Intradermally Followed by Electroporation in Healthy Volunteers[9].
  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+19'}[10].
  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19's ClinicalTrials.gov ID is recorded as NCT04447781[11].
  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+64'}[12].
  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19's research intervention is recorded as citric acid[13].
  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19's research intervention is recorded as trisodium citrate[14].
  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19's research intervention is recorded as INO-4800[15].
  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19's clinical trial phase is recorded as phase I clinical trial[16].
  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19's clinical trial phase is recorded as phase II clinical trial[17].
  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19's research subject recruitment status is recorded as not yet recruiting[18].
  • Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19's study type is recorded as interventional study[19].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . covid-19tracker.milkeninstitute.org. Retrieved . covid-19tracker.milkeninstitute.org. Provenance: wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . covid-19tracker.milkeninstitute.org. Retrieved . covid-19tracker.milkeninstitute.org. Provenance: wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.
  18. [19] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19. Retrieved May 3, 2026, from https://4ort.xyz/entity/safety-tolerability-and-immunogenicity-of-ino-4800-followed-by-electroporation-in-healthy-volunteers-for-covid19
MLA “Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/safety-tolerability-and-immunogenicity-of-ino-4800-followed-by-electroporation-in-healthy-volunteers-for-covid19.
BibTeX @misc{4ortxyz_safety-tolerability-and-immunogenicity-of-ino-4800-followed-by-electroporation-in-healthy-volunteers-for-covid19_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19}}, year = {2026}, url = {https://4ort.xyz/entity/safety-tolerability-and-immunogenicity-of-ino-4800-followed-by-electroporation-in-healthy-volunteers-for-covid19}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 — https://4ort.xyz/entity/safety-tolerability-and-immunogenicity-of-ino-4800-followed-by-electroporation-in-healthy-volunteers-for-covid19 (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/safety-tolerability-and-immunogenicity-of-ino-4800-followed-by-electroporation-in-healthy-volunteers-for-covid19 · Last refreshed: